Cigna Corporation (NYSE:CI) has been given an average recommendation of “Buy” by the eighteen analysts that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $200.67.
CI has been the subject of several recent analyst reports. Deutsche Bank raised their target price on Cigna from $180.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Morgan Stanley raised their target price on Cigna from $184.00 to $188.00 and gave the stock an “overweight” rating in a research note on Monday, August 7th. Citigroup raised their target price on Cigna from $185.00 to $198.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Zacks Investment Research cut Cigna from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th. Finally, Royal Bank Of Canada restated a “buy” rating and set a $185.00 price target on shares of Cigna in a research report on Wednesday, August 9th.
In related news, EVP Alan Muney sold 15,345 shares of Cigna stock in a transaction on Monday, November 27th. The stock was sold at an average price of $200.80, for a total value of $3,081,276.00. Following the completion of the transaction, the executive vice president now directly owns 28,457 shares in the company, valued at $5,714,165.60. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Christopher J. Hocevar sold 8,387 shares of Cigna stock in a transaction on Monday, November 27th. The shares were sold at an average price of $200.32, for a total value of $1,680,083.84. Following the completion of the transaction, the insider now owns 12,363 shares of the company’s stock, valued at $2,476,556.16. The disclosure for this sale can be found here. Over the last quarter, insiders sold 36,203 shares of company stock valued at $7,211,251. 1.30% of the stock is currently owned by company insiders.
Cigna (NYSE:CI) traded down $3.32 during mid-day trading on Thursday, reaching $208.41. The company’s stock had a trading volume of 1,442,418 shares, compared to its average volume of 1,208,917. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39. The firm has a market capitalization of $51,383.49, a PE ratio of 20.08, a price-to-earnings-growth ratio of 1.59 and a beta of 0.50. Cigna has a one year low of $131.03 and a one year high of $212.46.
Cigna (NYSE:CI) last posted its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.36 by $0.47. The company had revenue of $10.38 billion during the quarter, compared to analysts’ expectations of $10.17 billion. Cigna had a return on equity of 18.85% and a net margin of 5.74%. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.94 earnings per share. analysts predict that Cigna will post 10.34 EPS for the current fiscal year.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
What are top analysts saying about Cigna Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cigna Corporation and related companies.